# Genprex Announces New Research Identifying TROP2 as a Potential Predictive Biomarker to Reqorsa® Gene Therapy in Lung Cancer

- Source: PR Newswire M&A
- Published: 2026-11-04T12:00:00+00:00
- Category: Local
- Original: https://www.prnewswire.com/news-releases/genprex-announces-new-research-identifying-trop2-as-a-potential-predictive-biomarker-to-reqorsa-gene-therapy-in-lung-cancer-302928922.html
- Canonical: https://groundlevelnews.com/story/genprex-announces-new-research-identifying-trop2-as-a-potential-predic-eba359/

Research to be Presented at the 2026 EORTC-NCI-AACR Symposium Links TROP2 Expression to Treatment Response and Explores its Role in Treatment Sensitivity Findings Suggest Low TROP2 Expression is Associated with Primary Resistance to REQORSA and May Help Guide Patient Selection AUSTIN,...

_Ground Level News shows a short summary only; the full article and all rights belong to PR Newswire M&A._